GGrantIndex
Sort

82,697 grants matching vaccine development

Inhibitors and Probes of HIV-1 Cell Fusion

$887,367
Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK

Genetic, structural and functional profiling of the human antibody response to arenavirus infection

$887,255
Bryan Briney · Scripps Research Institute, The · R01 · FY2022 · AI

CEIRR: SARS-CoV-2 Research Activities

$887,250
Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2024 · AI

South African Medical Research Council Clinical Trials Unit (MRC CTU)

$887,214
Gita Ramjee · Medical Research Council Of South Africa · UM1 · FY2016 · AI

Chlamydial Immunity and Vaccine Development

$887,130
Harlan D Caldwell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI

Task A91: Small Animal Models for Biodefense Viruses

$886,965
Brian Gowen · Utah State University · N01 · FY2024 · AI

Immunogenicity and Efficacy of SARS-CoV-2 stabilized prefusion Spike protein vaccines in infant rhesus macaques

$886,934
Koen K Van Rompay · Duke University · P01 · FY2020 · AI

A Bioresorbable Subdermal Implant for Sustained Delivery of a Novel Maturation Inhibitor to Prevent HIV Infection

$886,859
John A Moss · Oak Crest Institute Of Science · R01 · FY2024 · AI

Interaction of HIV envelope with cell surface receptors

$886,780
Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

Production of Adenovector Based Vaccines

$886,735
Duncan L McVey · Genvec, Inc. · R44 · FY2010 · AI

Inhibitors and Probes of HIV-1 Cell Fusion

$886,717
Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2017 · DK

Inhibitors and Probes of HIV-1 Cell Fusion

$886,717
Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK

Inhibitors and Probes of HIV-1 Cell Fusion

$886,717
Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK

Inhibitors and Probes of HIV-1 Cell Fusion

$886,717
Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2018 · DK

Quintiles Clinical Trial Unit for HIV/AIDS Clinical Trials Networks

$886,623
Kathleen E. Squires · Quintiles Federated Services, Inc. · U01 · FY2009 · AI

Development of NHP Models for Infectious Pathogens of Man

$886,568
Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI

Persistent modulation of microbiota to enhance HIV vaccination

$886,454
Nichole Rose Klatt · University Of Washington · R01 · FY2016 · AI

Inhibitors and Probes of HIV-1 Cell Fusion

$886,324
Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK

A Mixed Methods Study of STI Co-Infections and Cervical Immune Microenvironment (

$886,273
Alberta Sum-Yu Kong · University Of New Mexico Health Scis Ctr · U19 · FY2018 · AI

PLATFORM TO DEVELOP LIVE ATTENUATED MULTIVALENT VACCINES AGAINST TICK-BORNE PATHOGENS

$886,257
Regents Of The University Of Minnesota · · FY2018 · Defense Health Agency

CCR Genomics Core

$886,180
Elizabeth Conner · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA

Improving the pharmacokinetics, potency, and immunogenicity of eCD4-Ig

$886,103
Charles Corbin Bailey · Emmune, Inc · R44 · FY2020 · AI

Immune Correlates for GM-CSF Mediated Enhancement of Vaccine Efficacy

$886,008
Rama Rao Amara · Emory University · U19 · FY2012 · AI

CANDIDA ADHERENCE MYCOLOGY RESEARCH UNIT

$885,941
La Biomed Res Inst/ Harbor Ucla Med Ctr · P01 · FY2001 · AI

Elicitation of HIV Broadly Neutralizing Antibodies from Engineered B cells

$885,861
James Even Voss · Scripps Research Institute, The · R01 · FY2021 · AI